Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1994 Sep;70(3):391–394. doi: 10.1038/bjc.1994.314

Oncology data management in the UK--BODMA's view. British Oncology Data Managers Association.

D Riley, L Ward, T Young
PMCID: PMC2033357  PMID: 8080719

Abstract

Over the past 10 years, the original partnership of clinician and statistician for the running of clinical research projects, especially clinical trials, has come to be supplemented by the data manager and trial coordinator. Increasing numbers of such personnel are now being employed, covering a wide diversity of work areas, including clinical research, medical audit and the cancer registries. The British Oncology Data Managers Association (BODMA) was founded in 1987 and is now in a good position to review the current status of data management in the UK. It is proposed that a national network of data managers and trial coordinators within specialist trials centres, oncology departments and district general hospitals, with a good training programme, plus a recognised career structure, is the way to make the best use of this key resource. BODMA is addressing many of these issues and aims to improve and maintain the quality of data management.

Full text

PDF
392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Farrar W. B. Clinical trials. Access and reimbursement. Cancer. 1991 Mar 15;67(6 Suppl):1779–1782. doi: 10.1002/cncr.2820671815. [DOI] [PubMed] [Google Scholar]
  2. Fleming I. D. Clinical trials for cancer patients. The community practicing physician's perspective. Cancer. 1990 May 15;65(10 Suppl):2388–2390. doi: 10.1002/1097-0142(19900515)65:10+<2388::aid-cncr2820651507>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  3. Fowkes F. G., Garraway W. M., Sheehy C. K. The quality of health services research in medical practice in the United Kingdom. J Epidemiol Community Health. 1991 Jun;45(2):102–106. doi: 10.1136/jech.45.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Franklin H. R., Kerr M., Tarayre M., Bierhorst F., Van Glabbeke M., Vantongelen K. Quality control of EORTC case report forms--wider implications for trial management. Eur J Cancer. 1992;28(2-3):610–611. doi: 10.1016/s0959-8049(05)80101-7. [DOI] [PubMed] [Google Scholar]
  5. Freedman L. S. The size of clinical trials in cancer research--what are the current needs? Medical Research Council Cancer Therapy Committee. Br J Cancer. 1989 Mar;59(3):396–400. doi: 10.1038/bjc.1989.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Friedman M. A., Cain D. F. National Cancer Institute sponsored cooperative clinical trials. Cancer. 1990 May 15;65(10 Suppl):2376–2382. doi: 10.1002/1097-0142(19900515)65:10+<2376::aid-cncr2820651504>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  7. Gelber R. D., Goldhirsch A. Can a clinical trial be the treatment of choice for patients with cancer? J Natl Cancer Inst. 1988 Aug 17;80(12):886–887. doi: 10.1093/jnci/80.12.886. [DOI] [PubMed] [Google Scholar]
  8. Meharchand J., Tannock I. Quality control in chemotherapy. Eur J Cancer. 1991;27(2):111–112. doi: 10.1016/0277-5379(91)90462-m. [DOI] [PubMed] [Google Scholar]
  9. Neaton J. D., Duchene A. G., Svendsen K. H., Wentworth D. An examination of the efficiency of some quality assurance methods commonly employed in clinical trials. Stat Med. 1990 Jan-Feb;9(1-2):115–124. doi: 10.1002/sim.4780090118. [DOI] [PubMed] [Google Scholar]
  10. Souhami R. L. Clinical trials in cancer: who should pay? Clin Oncol (R Coll Radiol) 1993;5(5):269–271. doi: 10.1016/s0936-6555(05)80897-0. [DOI] [PubMed] [Google Scholar]
  11. Vantongelen K., Rotmensz N., van der Schueren E. Quality control of validity of data collected in clinical trials. EORTC Study Group on Data Management (SGDM). Eur J Cancer Clin Oncol. 1989 Aug;25(8):1241–1247. doi: 10.1016/0277-5379(89)90421-5. [DOI] [PubMed] [Google Scholar]
  12. Vantongelen K., Steward W., Blackledge G., Verweij J., Van Oosterom A. EORTC joint ventures in quality control: treatment-related variables and data acquisition in chemotherapy trials. Eur J Cancer. 1991;27(2):201–207. doi: 10.1016/0277-5379(91)90488-y. [DOI] [PubMed] [Google Scholar]
  13. Ward L. The NHS as a developing market for cancer research. Lancet. 1992 Oct 3;340(8823):855–855. doi: 10.1016/0140-6736(92)92735-x. [DOI] [PubMed] [Google Scholar]
  14. Warlow C. How to do it. Organise a multicentre trial. BMJ. 1990 Jan 20;300(6718):180–183. doi: 10.1136/bmj.300.6718.180. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES